FACT: Christie Used His Seat On Trump’s Opioids Commission To Cash Out With Big Pharma

After shamelessly throwing his support behind Donald Trump during the 2016 election, Christie neglected his responsibilities as chair of Trump’s opioids commission and then used his position to land himself a lucrative consulting deal with Big Pharma.

As chair of Trump’s commission on opioids, Christie shirked his responsibilities and the commission was described as a “sham. ”

CBS News: “Christie, a supporter of the Trump campaign, was tapped by the president in March to chair the federal commission to combat opioid abuse, drug addiction and overdoses, which contributed to over 50,000 U.S. deaths in 2015. But so far, the effort has been off to a rocky start after the commission failed to make a deadline to file an interim report on the crisis for the second time back in July.”

CNN: “Opioid commission member: Our work is a ‘sham’”

CBS News: “As President Trump was briefed on combating the nation’s opioid epidemic in Bedminster, New Jersey, Gov. Chris Christie, Trump’s pick to lead the administration’s efforts on tackling drug addiction, was be missing the meeting because he’ll be on vacation.” 

Christie later used his position on the commission to get himself an over $800,000 consulting contract with Big Pharma.

Politico: “How Christie’s influence on opioid panel landed him an $800K consulting contract”

Politico: “Former New Jersey Gov. Chris Christie signed a lucrative consulting contract with a pharmaceutical company less than a year after President Donald Trump’s bipartisan commission on opioids and addiction, which Christie chaired, recommended policy changes the drugmaker sought.

“Pacira BioSciences paid Christie $800,000, plus stock options, in 2018 and 2019 as it lobbied for new Medicare rates to boost the financial prospects of its flagship product, a non-opioid painkiller used in surgeries, according to a POLITICO review of the New Jersey company’s regulatory filings.”